Your browser doesn't support javascript.
loading
Single-cell multi-omics of mitochondrial DNA disorders reveals dynamics of purifying selection across human immune cells.
Lareau, Caleb A; Dubois, Sonia M; Buquicchio, Frank A; Hsieh, Yu-Hsin; Garg, Kopal; Kautz, Pauline; Nitsch, Lena; Praktiknjo, Samantha D; Maschmeyer, Patrick; Verboon, Jeffrey M; Gutierrez, Jacob C; Yin, Yajie; Fiskin, Evgenij; Luo, Wendy; Mimitou, Eleni P; Muus, Christoph; Malhotra, Rhea; Parikh, Sumit; Fleming, Mark D; Oevermann, Lena; Schulte, Johannes; Eckert, Cornelia; Kundaje, Anshul; Smibert, Peter; Vardhana, Santosha A; Satpathy, Ansuman T; Regev, Aviv; Sankaran, Vijay G; Agarwal, Suneet; Ludwig, Leif S.
Afiliação
  • Lareau CA; Department of Pathology, Stanford University, Stanford, CA, USA. clareau@stanford.edu.
  • Dubois SM; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA. clareau@stanford.edu.
  • Buquicchio FA; Department of Genetics, Stanford University, Stanford, CA, USA. clareau@stanford.edu.
  • Hsieh YH; Broad Institute of MIT and Harvard, Cambridge, MA, USA. clareau@stanford.edu.
  • Garg K; Division of Hematology/Oncology, Boston Children's Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. clareau@stanford.edu.
  • Kautz P; Division of Hematology/Oncology, Boston Children's Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Nitsch L; Department of Pathology, Stanford University, Stanford, CA, USA.
  • Praktiknjo SD; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB), Berlin, Germany.
  • Maschmeyer P; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Verboon JM; Division of Hematology/Oncology, Boston Children's Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Gutierrez JC; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB), Berlin, Germany.
  • Yin Y; Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Fiskin E; Technische Universität Berlin, Institute of Biotechnology, Berlin, Germany.
  • Luo W; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB), Berlin, Germany.
  • Mimitou EP; Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Muus C; Department of Biology, Chemistry, Pharmacy, Freie Universität Berlin, Berlin, Germany.
  • Malhotra R; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB), Berlin, Germany.
  • Parikh S; Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Fleming MD; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB), Berlin, Germany.
  • Oevermann L; Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Schulte J; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Eckert C; Division of Hematology/Oncology, Boston Children's Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Kundaje A; Department of Pathology, Stanford University, Stanford, CA, USA.
  • Smibert P; Department of Pathology, Stanford University, Stanford, CA, USA.
  • Vardhana SA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Satpathy AT; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Regev A; Technology Innovation Lab, New York Genome Center, New York City, NY, USA.
  • Sankaran VG; Immunai, New York City, NY, USA.
  • Agarwal S; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Ludwig LS; Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.
Nat Genet ; 55(7): 1198-1209, 2023 07.
Article em En | MEDLINE | ID: mdl-37386249
Pathogenic mutations in mitochondrial DNA (mtDNA) compromise cellular metabolism, contributing to cellular heterogeneity and disease. Diverse mutations are associated with diverse clinical phenotypes, suggesting distinct organ- and cell-type-specific metabolic vulnerabilities. Here we establish a multi-omics approach to quantify deletions in mtDNA alongside cell state features in single cells derived from six patients across the phenotypic spectrum of single large-scale mtDNA deletions (SLSMDs). By profiling 206,663 cells, we reveal the dynamics of pathogenic mtDNA deletion heteroplasmy consistent with purifying selection and distinct metabolic vulnerabilities across T-cell states in vivo and validate these observations in vitro. By extending analyses to hematopoietic and erythroid progenitors, we reveal mtDNA dynamics and cell-type-specific gene regulatory adaptations, demonstrating the context-dependence of perturbing mitochondrial genomic integrity. Collectively, we report pathogenic mtDNA heteroplasmy dynamics of individual blood and immune cells across lineages, demonstrating the power of single-cell multi-omics for revealing fundamental properties of mitochondrial genetics.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: DNA Mitocondrial / Doenças Mitocondriais Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: DNA Mitocondrial / Doenças Mitocondriais Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article